The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention.
about
Folic acid in pregnancy and fetal outcomesAdvantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy RegistryDoes acute maternal stress in pregnancy affect infant health outcomes? Examination of a large cohort of infants born after the terrorist attacks of September 11, 2001Identifying birth defects in automated data sources in the Vaccine Safety DatalinkAntiretroviral therapy, pregnancy, and birth defects: a discussion on the updated data.Using an existing birth defects surveillance program to enhance surveillance data on stillbirths.Random error and undercounting in birth defects surveillance data: implications for inference.Fetal death certificates as a source of surveillance data for stillbirths with birth defectsExposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations.Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects.Bias toward the null hypothesis in pregnancy drug studies that do not include data on medical terminations of pregnancy: the folic acid antagonists.Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USAEfavirenz use during pregnancy and for women of child-bearing potentialPreconception care for improving perinatal outcomes: the time to actShould Men Take Prenatal Vitamins?The prevalence of congenital malformations and its correlation with consanguineous marriages.The National Down Syndrome Project: design and implementationGenetic epidemiology and primary care.Prevalence of esophageal atresia among 18 international birth defects surveillance programsQuantifying geocode location error using GIS methodsEvaluation of an active surveillance system for stillbirths in metropolitan Atlanta.Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up studyPericonceptional folate deficiency and implications in neural tube defects.The fetal safety of clomiphene citrate: a population-based retrospective cohort study.Fetal safety of macrolidesBirth Defects Surveillance in the United States: Challenges and Implications of International Classification of Diseases, Tenth Revision, Clinical Modification Implementation.Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural SenegalInclusion and exclusion criteria for malformations in newborn infants exposed to potential teratogens.Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.The Ribavirin Pregnancy Registry: An Interim Analysis of Potential Teratogenicity at the Mid-Point of Enrollment.Socioeconomic status and prevalence of congenital heart defects: does universal access to health care system eliminate the gap?Epidemiology of congenital anomalies of the central nervous system in children in Enugu, Nigeria: A retrospective study.Prevalence and trends of selected congenital malformations in New York State, 1983 to 2007.Health outcomes among infants born to women deployed to United States military operations during pregnancy.Risk factors for congenital diaphragmatic hernia in the Bogota birth defects surveillance and follow-up program, Colombia.The safety of H(2)-blockers use during pregnancy.Postpartum depression and timing of spousal military deployment relative to pregnancy and delivery.The safety of fetal exposure to proton-pump inhibitors during pregnancy.Birth weight in children with birth defects.Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations.
P2860
Q22337184-2A379BBC-BD70-4A2A-B6DF-438827C4F065Q26858860-70C78247-7B15-4120-86EF-74F993092396Q28390417-ED79A7D7-5B6A-4955-BF56-260922F99508Q28595391-8DB7E282-E99B-4BC3-8EE6-3F9D2686FF37Q30661395-C5B11455-773D-4AE1-AA10-88FD19DE019FQ30828672-B04A1A7B-BC54-4644-9811-4C81C9AEDFC3Q30886993-60073C06-C49C-4D84-BFA5-7E756898D843Q31129859-88C63CC2-D6DF-4F0F-A7E4-504333E0F805Q33608040-26D91830-3E74-42A0-B162-ADA3C9522DE2Q33708697-511E2441-06E4-4BE5-8338-998A5216E718Q33827209-A0DD4DD2-EABF-4EA4-8B64-214233A7B99EQ34440857-2677C347-9398-48A4-AA25-D93A0E561342Q34632385-5E7687AB-C800-44B1-A17E-CC1D98FEE080Q35069618-ECE3285D-98E7-4921-8D2B-DC39259FC4F2Q35156685-0560B152-AE7C-4E1F-9CDD-80FBFEC877DBQ35547827-3C367AAD-FEB0-4498-9F43-29566C53BE7AQ35645989-DDD2B34D-6D9C-43F0-A6E7-A5382F82EC8DQ35688722-70D6C403-4FA5-4EDC-A9E0-14C7DEFFAB7BQ35741830-BFAC42E5-4110-4983-B946-41F73E8A0E2FQ35752783-5550890B-3C40-420C-84ED-2C403594C33CQ35939902-29284EB7-D8B4-45B0-AE37-5A963A586A7CQ36110582-491FB342-4F3A-460B-92A9-7D172BB28141Q36151451-0FA736D7-0ED8-440C-99CD-DA9EE1C5449FQ36320450-03FB8AB2-1ED0-4B60-A91D-BA99BF8EE075Q36969814-F5F828EA-1760-462D-BDBC-E18B38250341Q36980002-33AF80F8-EB5D-4062-9D4A-92B4AD44411CQ36987050-3FCB0011-75E1-487D-A1DD-1D09C7AEB748Q37908003-E6F73387-7651-49C7-AD5C-DAC7B6653ADBQ37913349-C717FBD6-B5F9-4442-99CD-9118B4AB4D44Q38374336-28B163B6-153F-465D-8B69-393D648D7C0DQ38482708-F40BB034-B2F0-4920-BD5A-682DEA748524Q38934225-C5347127-BD34-460C-BA82-06A7B7118542Q39372916-78C25D8E-D8FC-446D-B450-88E7D0FA7F07Q39783242-5669C914-1A90-4474-A4B5-D93E2459B70DQ40318004-11C885DC-B654-4AD0-A557-EFCCA719C44CQ40378564-F743D352-267A-48D0-849C-01597B387080Q41323092-9C04F810-F885-4E9D-86E9-04D61D5808A9Q46326077-F28A842F-4551-46EA-ACBA-56177ED6A5CDQ47395015-A4591B57-7417-4FDA-8134-F406F4A5AE1BQ47826642-34DE33F0-CA37-4750-986C-5BD58D359769
P2860
The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The Metropolitan Atlanta Conge ...... isease Control and Prevention.
@en
The Metropolitan Atlanta Conge ...... isease Control and Prevention.
@nl
type
label
The Metropolitan Atlanta Conge ...... isease Control and Prevention.
@en
The Metropolitan Atlanta Conge ...... isease Control and Prevention.
@nl
prefLabel
The Metropolitan Atlanta Conge ...... isease Control and Prevention.
@en
The Metropolitan Atlanta Conge ...... isease Control and Prevention.
@nl
P2093
P2860
P356
P1476
The Metropolitan Atlanta Conge ...... isease Control and Prevention.
@en
P2093
Adolfo Correa-Villaseñor
Csaba Siffel
James Kucik
Janet Cragan
Laura Williams
Leslie O'Leary
P2860
P304
P356
10.1002/BDRA.10111
P577
2003-09-01T00:00:00Z